The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Diagnostic strategies for unknown primary cancer
Open accessAbstract
Unknown primary cancer (UPC) is defined by the presence of metastatic disease for which a primary site is undetectable on presentation. Computed tomography scan of the body was performed routinely in search of the primary cancer and invasive procedures were pursued in selective cases. Magnetic resonance imaging of the breast enables identification of an occult breast primary tumor in ≤ 75% of women who present with adenocarcinoma in the axillary lymph nodes and can influence surgical management. Positron emission tomography scan also can be used in the diagnosis of UPCs, but its value is controversial. Cytokeratins 7 and 20 and thyroid transcription factor are some of the histochemical markers used in most patients who present with metastatic adenocarcinoma. Some of the newly discovered immunohistochemical markers further assist in narrowing the differential diagnosis. The role of molecular profiling to make the diagnosis, establish the prognosis, and assess the response to treatment in UPCs is evolving. The authors discuss the role of histochemical markers in the diagnosis of UPC and the most recent data regarding the use of imaging and invasive diagnostic modalities and gene expression profiles. Cancer 2004. © 2004 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
Lazzaro, D., Price, M., Felice, M. D., & Lauro, R. D. (1991) · Development · doi:10.1242/dev.113.4.1093 · Cited by 901
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
Moll, R., Löwe, A., Laufer, J., & Franke, W. W. (1992) · PubMed Central · Cited by 806
Molecular classification of human carcinomas by use of gene expression signatures.
Su, A. I., Welsh, J. B., Sapinoso, L. M., Kern, S. G., Dimitrov, P., Lapp, H., Schultz, P. G., Powell, S. M., Moskaluk, C. A., Frierson, H. F., et al. (2001) · PubMed · Cited by 688
Guazzi, S., Price, M., De Felice, M., Damante, G., Mattei, M. G., & Di Lauro, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07574.x · Cited by 535
Moll, R., Schiller, D. L., & Franke, W. W. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.567 · Cited by 367
Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.
Abbruzzese, J. L., Abbruzzese, M. C., Lenzi, R., Hess, K. R., & Raber, M. N. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.8.2094 · Cited by 320
Self-citation
Cited by
Deep learning in cancer diagnosis, prognosis and treatment selection
Tran, K. A., Kondrashova, O., Bradley, A., Williams, E. D., Pearson, J. V., & Waddell, N. (2021) · Genome Medicine · doi:10.1186/s13073-021-00968-x · Cited by 932
MicroRNAs accurately identify cancer tissue origin
Rosenfeld, N., Aharonov, R., Meiri, E., Rosenwald, S., Spector, Y., Zepeniuk, M., Benjamin, H., Shabes, N., Tabak, S., Levy, A., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1392 · Cited by 812
Dennis, J. L., Hvidsten, T. R., Wit, E. C., Komorowski, J., Bell, A. K., Downie, I., Mooney, J., Verbeke, C., Bellamy, C., Keith, W. N., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2236 · Cited by 320
Advancing Cancer Research and Medicine with Single-Cell Genomics
Lim, B., Lin, Y., & Navin, N. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.008 · Cited by 302
Metadata
- Authors
- Varadhachary, G. R., Abbruzzese, J. L., & Lenzi, R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-03-22
- Volume
- 100
- Issue
- 9
- Pages
- 1776-1785
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2088103367
- Cited by
- 266
- References
- 26
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic strategies for unknown primary cancer. https://app.cochat.ai/papers/10.1002/cncr.20202
- The paper
- Varadhachary, G. R., Abbruzzese, J. L., & Lenzi, R. (2004). Diagnostic strategies for unknown primary cancer. Cancer. https://doi.org/10.1002/cncr.20202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.